Your session is about to expire
← Back to Search
Study Summary
This trial will test whether botulinum toxin type A can prevent atrial fibrillation after open-chest cardiac surgery.
- Post-operative Atrial Fibrillation
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Frequently Asked Questions
Are patients who are over 55 years old able to participate in this clinical trial?
"This geriatric clinical trial is looking for patients who are within the age bracket of 55 to 90 years old."
Is this trial available in many locations within the city?
"Currently, this clinical trial is operational in 26 locations. They are situated in Falls Church, Saint Louis, and Montréal as well as 24 other sites. If you enroll in the trial, it would be advantageous to pick a location near you to limit travel needs."
Are there any available spots for new participants in this trial?
"Unfortunately, this particular clinical trial is not recruiting at the moment. According to information on clinicaltrials.gov, it was initially posted on March 1st 2019 and edited for the last time on April 8th 2022. Even though this study isn't looking for volunteers right now, there are 501 other trials that are currently enrolling patients."
What is the AGN-151607's regulatory status?
"AGN-151607's safety is based on Phase 2 trial data, which means that while there is some evidence indicating it is safe, there is no indication of its efficacy."
Can I qualify to participate in this research?
"This trial is recruiting 330 patients with atrial fibrillation aged 55 and 90. Most importantly, patients should meet the following criteria: Written informed consent from the participant has been obtained prior to any study-related procedures, Capable of giving signed informed consent, which includes compliance with the requirements and restrictions listed in the informed consent form., Written documentation has been obtained in accordance with the relevant country and local privacy requirements, where applicable (eg. Written Authorization for Use and Release of Health and Research Study Information [US sites] and written Data Protection consent (European Union sites)., Participants who are scheduled to undergo open-chest cardiac surgery"
Share this study with friends
Copy Link
Messenger